 NRx Pharmaceuticals Inc NASDAQ: NRXP and Quantum Leap Healthcare Collaborative have begun treating patients with inhaled Zyesami Aviptadil in the I-SPY COVID Trial. The I-SPY COVID Trial utilizes Quantum Leaps adaptive platform trial design methodology, which focuses on the efficient assessment of multiple investigational agents simultaneously. 